These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32468937)

  • 1. Antiphospholipid syndrome and challenges with direct oral anticoagulants.
    Booth S; Burton K; Hunt B; Desborough M
    Br J Hosp Med (Lond); 2020 May; 81(5):1-11. PubMed ID: 32468937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
    Cervera R; Espinosa G
    Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid Syndrome in Patients with Venous Thromboembolism.
    Pengo V; Denas G
    Semin Thromb Hemost; 2023 Nov; 49(8):833-839. PubMed ID: 35728601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
    Arachchillage DRJ; Laffan M
    Br J Haematol; 2020 Apr; 189(2):216-227. PubMed ID: 32108324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    Zuily S; Cohen H; Isenberg D; Woller SC; Crowther M; Dufrost V; Wahl D; Doré CJ; Cuker A; Carrier M; Pengo V; Devreese KMJ
    J Thromb Haemost; 2020 Sep; 18(9):2126-2137. PubMed ID: 32881337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
    Pengo V; Denas G
    Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine and the antiphospholipid syndrome: what is the future?
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Clin Rheumatol; 2020 Apr; 39(4):1015-1017. PubMed ID: 32060811
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome.
    Hernández-Molina G; Espericueta-Arriola G; Cabral AR
    Clin Exp Rheumatol; 2013; 31(3):382-8. PubMed ID: 23305633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
    Girolami A; Zanon E; Zanardi S; Saracino MA; Simioni P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):497-501. PubMed ID: 8840004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
    Cohen H; Efthymiou M; Gates C; Isenberg D
    Semin Thromb Hemost; 2018 Jul; 44(5):427-438. PubMed ID: 28196381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphospholipid antibodies--risk factors for venous thromboembolism and arterial thrombosis].
    Zawilska K
    Pol Arch Med Wewn; 2007; 117 Suppl():41-5. PubMed ID: 18778019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic antiphospholipid syndrome: From guidelines to clinical management.
    Paredes-Ruiz D; Martin-Iglesias D; Ruiz-Irastorza G
    Med Clin (Barc); 2024 Aug; 163 Suppl 1():S22-S30. PubMed ID: 39174150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lupus anticoagulant/antiphospholipid syndrome.
    Shapiro SS
    Annu Rev Med; 1996; 47():533-53. PubMed ID: 8712801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of antiphospholipid syndrome.
    Bertolaccini ML; Khamashta MA
    Expert Rev Hematol; 2008 Dec; 1(2):183-8. PubMed ID: 21082923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiphospholipid antibody syndrome.
    Bolling JP; Brown GC
    Curr Opin Ophthalmol; 2000 Jun; 11(3):211-3. PubMed ID: 10977230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.